Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cartesian Therapeutics (RNAC) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to -$19.5 million.

  • Cartesian Therapeutics' Income towards Parent Company fell 3010.27% to -$19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.7 million, marking a year-over-year increase of 5991.61%. This contributed to the annual value of -$77.4 million for FY2024, which is 6476.08% up from last year.
  • Latest data reveals that Cartesian Therapeutics reported Income towards Parent Company of -$19.5 million as of Q3 2025, which was down 3010.27% from -$20.1 million recorded in Q2 2025.
  • Cartesian Therapeutics' Income towards Parent Company's 5-year high stood at $15.0 million during Q2 2024, with a 5-year trough of -$196.7 million in Q4 2023.
  • Its 5-year average for Income towards Parent Company is -$17.4 million, with a median of -$12.2 million in 2024.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 550566.8% in 2022, then plummeted by 343714.58% in 2023.
  • Cartesian Therapeutics' Income towards Parent Company (Quarter) stood at $12.2 million in 2021, then tumbled by 51.85% to $5.9 million in 2022, then tumbled by 3437.15% to -$196.7 million in 2023, then soared by 87.66% to -$24.3 million in 2024, then grew by 19.6% to -$19.5 million in 2025.
  • Its Income towards Parent Company was -$19.5 million in Q3 2025, compared to -$20.1 million in Q2 2025 and -$19.9 million in Q1 2025.